Clinical Trials
All Clinical Trials - Page 33 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05162183N/ACompleted
Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data
Liraglutide
- NCT03648554Phase 4Unknown
Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
Dulaglutide
- NCT04039503Phase 3Completed
A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
Tirzepatide
- NCT04074317Phase 2Completed
Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D
Pramlintide
- NCT04004988Phase 1Completed
A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants
Tirzepatide
- NCT04076462Phase 3Completed
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Octreotide
- NCT03841058Phase 2Active Not Recruiting
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Abaloparatide
- NCT04032197Phase 1Completed
A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetes
Semaglutide
- NCT04064411Phase 3Completed
Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis
Abaloparatide
- NCT04126603Phase 4Completed
Impact of Semaglutide on CD34+ EPC and Fat Derived MSC
Semaglutide
- NCT03770728Phase 3Terminated
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea
Efpeglenatide
- NCT04037488N/AUnknown
Changes in Body Composition With Patients Under Androgen Deprivation Therapy
Gonadorelin
- NCT03895463N/AWithdrawn
Study to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) in Routine Clinical Practice
Lanreotide
- NCT03987919Phase 3Completed
A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
Tirzepatide
- NCT03987074Phase 2Completed
Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)
Semaglutide
- NCT04017832Phase 3Completed
A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes
Semaglutide
- NCT03967249Phase 2Completed
Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands
Octreotide
- NCT03884075Phase 2Recruiting
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
Semaglutide
- NCT03940742Phase 1Completed
A Study of Tirzepatide in Participants With Impaired Liver Function
Tirzepatide
- NCT04029272Phase 4Unknown
Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients
Exenatide
- NCT04028323Phase 4Unknown
Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903)
Octreotide
- NCT04012255Phase 1Terminated
A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
Semaglutide
- NCT03798912Phase 1Completed
A First-in-Human Study of the RaniPill, an Oral Drug Delivery Platform
Octreotide
- NCT03947762N/ATerminated
Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice.
Lanreotide
- NCT03970044Phase 4Completed
Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
Exenatide
- NCT03996434Phase 4Completed
Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS
Gonadorelin
- NCT03989024Phase 4Unknown
Pulsatile Gonadotropin-releasing Hormone for Infertility in Non-obese Patients With Polycystic Ovary Syndrome
Gonadorelin
- NCT03994172Phase 4Completed
Novel Combination Therapy for Osteoporosis in Men
Teriparatide
- NCT01311518Phase 2Withdrawn
A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction
TB-500
- NCT04003467Phase 2Completed
A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass
Teriparatide
- NCT03951753Phase 1Completed
A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)
Tirzepatide
- NCT04007107Phase 2Completed
A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
Semaglutide
- NCT04027348Phase 2Terminated
Palliative Management of Inoperable Malignant Bowel Obstruction
Octreotide
- NCT03948347N/AUnknown
Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus
Liraglutide
- NCT03421119Phase 3Unknown
Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes
Liraglutide
- NCT03989232Phase 3Completed
A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
Semaglutide
- NCT03987451Phase 2Completed
A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage
Semaglutide
- NCT03819153Phase 3Completed
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease
Semaglutide
- NCT03914326Phase 3Completed
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Semaglutide
- NCT03973047Phase 1Completed
Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran
PT-141
- NCT03879694Phase 1Completed
Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors
Octreotide
- NCT03946527Phase 2Active Not Recruiting
LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)
Lanreotide
- NCT03929744Phase 1Completed
A Study of LY3502970 in Healthy Participants
Orforglipron
- NCT03822468Phase 2Completed
Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer
Gonadorelin
- NCT03981627Phase 1/Phase 2Completed
A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus
Pramlintide
- NCT03954834Phase 3Completed
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
Tirzepatide
- NCT03962010Phase 2Unknown
A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus
Dulaglutide
- NCT04126941N/AUnknown
Monocentric Study on the Use of Teriparatide in Children With hypoparathyroïdism
Teriparatide
- NCT04206618N/ACompleted
Circulating Myokine Levels and Bone Metabolism
Teriparatide
- NCT03929679N/ACompleted
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)
Semaglutide